A Brightlands Science lecture on: “Engineering instructive biomaterials for regenerative medicine”, by Prof. dr. Pamela Habibovic (MERLN) and kickstart lecture by Dr. Niloofar Tahmasebi (Maastricht University) on: “Instructive biomaterials beyond nature”.
After the two Lectures, Professor Habibovic will join an in-depth panel discussion to reflect further on tissue engineering from different angles: laws and regulations, practical implications in clinics, and insights from the industry, together with Pieter Emans, orthopedic surgeon, MUMC+, Jessica Gerards, GMP-specialist at Medace and Jens Thies, Director of Science & Innovation at DSM Biomedical.
More info and registration: https://www.brightlands.com/brightlands-chemelot-campus/event/brightlands-science-lecture-prof-dr-pamela-habibovic
Life Science Innovation Network Japan (LINK-J) steps forward to launch a series of business partnering event “Advanced Therapy Showcase in Tokyo,” and is preparing for its first edition planned to be virtually held in Tokyo, Japan, on January 21, 2021.
Biotech Showcase™ Digital is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives. By necessity we have gone fully digital and expanded the format to five 24-hour days to accommodate partnering meetings all over the world.
The 2020 conference of the Tissue Engineering and Regenerative Medicine International Society – Americas Chapter (TERMIS-AM) will be held in Toronto, ON, Canada in December.
December 2-3, 2020: Breaking Through brings together Canadian and international leaders to explore the past, present, and future of somatic gene therapy research and practice. This two-day virtual event will examine the successes, challenges and opportunities from the bench to the bedside. It will also feature the CCA Expert Panel on the Approval and Use of Somatic Gene Therapies in Canada, who will discuss the findings and implications of their report, From Research to Reality.
To find out more about this symposium, and to download the agenda, visit www.breaking-through.ca.
https://summit2020.acgtfoundation.org/
For nearly 20 years, the Alliance for Cancer Gene Therapy has funded cell and gene therapy research that has led to a paradigm shift in how cancer is treated today. Our funding led to the CAR-T breakthroughs that launched a new era in oncology and new hope for patients with blood cancers.
On April 16, 2020, we are convening thought-leaders in cancer cell and gene therapy to continue that work. With a focus on solid tumors, we will share the latest advances, address the greatest challenges and showcase the most innovative programs in progress today.
Incredible breakthroughs have been made but many people living with cancer have yet to see the benefits.
As a leader in cancer cell and gene therapy, we invite you to join us at the Alexandria Center for Life Science in New York City on April 16, 2020 to celebrate the successes and attack the challenges as we work to eliminate cancer in our lifetime.
The 26th annual BIO-Europe®event is the largest biotechnology partnering conference held in Europe, though in 2020 by necessity we have gone fully digital and expanded the format to four 24-hour days to accommodate partnering meetings all over the world.
Over 4,400 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners.
BIO-Europe features the industry’s most advanced partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
BIO-Europe’s world-class workshops, panels, company presentations, and showcasing companies and sponsors (all of which will be pre-recorded and available to view throughout the event) along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to do business. Learn more.
The ARMI | BioFabUSA Fall Meeting in the Millyard is 100% virtual. Join us every Tuesday in October as we look at Defining a New Paradigm.
Registration Link: https://event.on24.com/eventRegistration/EventLobbyServlet?eventid=2573701&key=DE50B6B184872F2078A673B0918C88FC&mc_cid=53691b98e6&mc_eid=[UNIQID]®Tag=1463159&sessionid=1&sourcepage=register&target=reg20.jsp
